These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20136479)

  • 21. Combination treatment with guanfacine extended release and blonanserin for Tourette's syndrome comorbid with attention deficit hyperactivity disorder.
    Kawabe K; Horiuchi F; Ueno SI
    Psychiatry Clin Neurosci; 2019 Dec; 73(12):762-763. PubMed ID: 31588606
    [No Abstract]   [Full Text] [Related]  

  • 22. [Analgetic effect of guanfacine in postoperative period].
    Strashnov VI; Bogdanov EG
    Anesteziol Reanimatol; 1996; (4):43-4. PubMed ID: 8975571
    [No Abstract]   [Full Text] [Related]  

  • 23. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment.
    Neylan TC; Lenoci M; Samuelson KW; Metzler TJ; Henn-Haase C; Hierholzer RW; Lindley SE; Otte C; Schoenfeld FB; Yesavage JA; Marmar CR
    Am J Psychiatry; 2006 Dec; 163(12):2186-8. PubMed ID: 17151174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive therapy with guanfacine induces elevated plasma growth hormone levels in diabetic patients.
    Coves MJ; Gomis R; Casamitjana R; Lienas V; Vilaradell E
    J Med; 1989; 20(3-4):291-6. PubMed ID: 2572660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term antihypertensive therapy with guanfacine.
    Szám I; Holló J
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):388-92. PubMed ID: 6749702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of central alpha 2-adrenergic agonists on systemic haemodynamics and on baroreceptor reflex sensitivity in spontaneously hypertensive rats.
    Fischetti F; Fabris B; Calci M; Candido R; Armini L; Bardelli M; Cominotto F; Biagi A; Carretta R
    Boll Soc Ital Biol Sper; 1994; 70(10-11):279-86. PubMed ID: 7702832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A somnolent 2-year-old boy with a hyperactive brother.
    Fontane E; Shiber J
    Pediatr Emerg Care; 2013 Sep; 29(9):1033-6. PubMed ID: 24201989
    [No Abstract]   [Full Text] [Related]  

  • 28. Introduction: new developments in the treatment of attention-deficit/hyperactivity disorder.
    Biederman J
    J Clin Psychiatry; 2006; 67 Suppl 8():4-6. PubMed ID: 16961423
    [No Abstract]   [Full Text] [Related]  

  • 29. Guanfacine and secondary mania in children.
    Horrigan JP; Barnhill LJ
    J Affect Disord; 1999 Aug; 54(3):309-14. PubMed ID: 10467976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of torsades de pointes induced by severe QT prolongation after an overdose of eperisone and triazolam in a patient receiving nifedipine.
    Yamagiwa T; Amino M; Morita S; Yamamoto R; Saito T; Inokuchi S
    Clin Toxicol (Phila); 2010 Feb; 48(2):149-52. PubMed ID: 20199131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. QT-Interval Prolongation Associated with Supratherapeutic Guanfacine Concentration: A Case Report.
    Inoue F; Okazaki Y; Kashiwa K; Ichiba T; Namera A
    J Med Toxicol; 2024 Apr; 20(2):218-221. PubMed ID: 38231419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of Tourette's syndrome with symptoms of attention deficit disorder treated with desipramine.
    Hoge SK; Biederman J
    J Clin Psychiatry; 1986 Sep; 47(9):478-9. PubMed ID: 3462186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed salicylate toxicity at 35 hours without early manifestations following a single salicylate ingestion.
    Rivera W; Kleinschmidt KC; Velez LI; Shepherd G; Keyes DC
    Ann Pharmacother; 2004; 38(7-8):1186-8. PubMed ID: 15173556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
    Biederman J; Melmed RD; Patel A; McBurnett K; Konow J; Lyne A; Scherer N;
    Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In the pipeline: non-stimulant ADHD meds.
    Glazer WM
    Behav Healthc; 2010 Jan; 30(1):30-1. PubMed ID: 20184258
    [No Abstract]   [Full Text] [Related]  

  • 36. Orthostatic hypotension occurring after discontinuation of long-term minoxidil therapy.
    Noel HC
    Nurse Pract; 1988 Aug; 13(8):25, 28, 30-2. PubMed ID: 3173816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orthotopic liver transplants necessitated by acetaminophen-induced hepatotoxicity.
    Mrvos R; Schneider SM; Dean BS; Krenzelok EP
    Vet Hum Toxicol; 1992 Oct; 34(5):425-7. PubMed ID: 1455612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiotoxicity after massive amantadine overdose.
    Schwartz M; Patel M; Kazzi Z; Morgan B
    J Med Toxicol; 2008 Sep; 4(3):173-9. PubMed ID: 18821491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two case reports of extended-release guanfacine overdose in children.
    Shimozato A; Ohashi K; Saitoh S
    Pediatr Int; 2023 Jan; 65(1):e15424. PubMed ID: 36412228
    [No Abstract]   [Full Text] [Related]  

  • 40. Delayed dystonia following pimozide overdose in a child.
    Gair RD; Friesen MS; Kent DA
    J Toxicol Clin Toxicol; 2004; 42(7):977-81. PubMed ID: 15641643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.